Variants of PNPLA3 polymorphisms were proven to be associated with NAFLD/NASH, together with the polymorphisms of the transmembrane 6 superfamily member 2 (TM6SF2) gene [21]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.